Abnormal solubilization by triton X-100 of erythrocyte membranes from patients with paroxysmal nocturnal hemoglobinuria.
D000743:Anemia, Hemolytic / Q000097:blood; D000818:Animals; D001798:Blood Proteins / Q000032:analysis; D002462:Cell Membrane / Q000032:analysis / Q000187:drug effects / Q000276:immunology; D002469:Cell Separation; D002498:Centrifugation; D002784:Cholesterol / Q000097:blood; D004591:Electrophoresis, Polyacrylamide Gel; D004906:Erythrocyte Count; D004912:Erythrocytes / Q000187:drug effects* / Q000276:immunology; D006457:Hemoglobinuria, Paroxysmal / Q000097:blood*; D006461:Hemolysis; D006601:Hexoses / Q000097:blood; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D011092:Polyethylene Glycols / Q000494:pharmacology*; D011817:Rabbits / Q000276:immunology; D012156:Reticulocytes; D012995:Solubility; D013501:Surface-Active Agents / Q000494:pharmacology*
D001798:Blood Proteins; D006601:Hexoses; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D002784:Cholesterol